Prosecution Insights
Last updated: November 20, 2026
Application No. 18/681,472

THERMALLY RESISTANT POLYAMIDE

Final Rejection §103
Filed
Feb 05, 2024
Priority
Aug 03, 2021 — EU 21306080.9 +1 more
Examiner
DU, SURBHI M
Art Unit
1765
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Syensqo Specialty Polymers Usa LLC
OA Round
2 (Final)
67%
Grant Probability
Favorable
3-4
OA Rounds
5m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 67% — above average
67%
Career Allowance Rate
83 granted / 124 resolved
+1.9% vs TC avg
Strong +29% interview lift
Without
With
+29.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
36 currently pending
Career history
175
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
57.9%
+17.9% vs TC avg
§102
17.5%
-22.5% vs TC avg
§112
18.1%
-21.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 124 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1, 11-12, 16, 19, 38, 42-43 and 45-51 are rejected under 35 U.S.C. 103 as being unpatentable over Oda et al. JP2015-017177A. Regarding claims 1,11-12,19 and 46-50, Oda teaches (reference claim 1) a polyamide resin which is generated by polycondensing a polyamide oligomer containing a diamine unit which can be selected to be an alicyclic diamine unit represented by the following general formula (I-2) and a dicarboxylic acid unit selected from a linear aliphatic dicarboxylic acid unit represented by the following general formula (II-1) and an aromatic dicarboxylic acid unit represented by the following general formula (II-2), to adjust the crystallinity and moldability of the polyamide (para [0019]). PNG media_image1.png 130 251 media_image1.png Greyscale PNG media_image2.png 126 457 media_image2.png Greyscale Oda discloses that alicyclic diamine unit represented by General Formula (I-2) include 1,3-bis(aminomethyl)cyclohexane, which can be used alone (para [0014]). Oda notes that the aliphatic dicarboxylic acid unit can be selected to be adipic acid (para [0021]) and that terephthalic acid is a preferred aromatic dicarboxylic acid (para [0024]). Oda adds that the dicarboxylic acid unit in the polyamide, the content ratio of the linear aliphatic dicarboxylic acid unit and the aromatic dicarboxylic acid unit (linear aliphatic dicarboxylic acid unit / aromatic dicarboxylic acid unit) is appropriately determined depending on the application. For tuning the glass-transition temperature (Tg) of the polyamide resins and to decrease the crystallinity of the polyamide resins, the molar ratio of the linear aliphatic dicarboxylic unit / the aromatic dicarboxylic unit is preferably 0/100-30/70 (para [0026]). Oda provides two embodiments Production Example 3 (para [0079]), which is generated by monomers 1,3-bis(aminomethyl)cyclohexane and adipic acid; and Production Example 5 (with Mn 24,550 g/mol, Example 5, Table 2) which is created by condensation of 1,3-bis(aminomethyl)cyclohexane and terephthalic acid (para [0081]) with 1,3-bisaminomethylcyclohexane having a cis/trans ratio of 70/30, meeting the claimed requirement (instant claim 50). It would have been obvious to one of ordinary skilled in the art before the effective filing date of the invention to have substituted small amount 5 mol% of terephthalic acid in Oda’s Production Example 5 with adipic acid (where 5 mol% adipic acid lies within Oda’s recommended mol% of aliphatic dicarboxylic acid), while maintaining the same molecular weight (Mn, see Table 2, Ex 5), for the same application of creating a polyamide with decreased crystallinity. Such an obvious composition satisfies the claimed repeat units of 95 mol% RPA1 and 5 mol% RPA3. Since, obvious composition of Oda with the required repeat units, proportions and molecular weight Mn consistent with the specification, is substantially identical to instant inventive E5, the thermal properties Tg, Tm and ∆Hf would necessarily follow (instant claims 46-49). Applicant’s attention is directed to: Where the claimed and prior art products are identical or substantially identical in structure or composition, or are produced by identical or substantially identical processes, a prima facie case of either anticipation or obviousness has been established. In re Best, 562 F.2d 1252, 1255, 195 USPQ 430, 433 (CCPA 1977). "When the PTO shows a sound basis for believing that the products of the applicant and the prior art are the same, the applicant has the burden of showing that they are not." In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). See MPEP 2112.01. Regarding claim 16, Oda teaches that aromatic dicarboxylic terephthalic acid and isophthalic acid can be used together in a combination of two (paras [0024] and [0025]) and recommends smaller fraction of isophthalic acid when combined with terephthalic acid such that the ratio of (isophthalic acid unit / terephthalic acid unit) is in the range 0/100-30/70. Since the incorporation of isophthalic acid is known to decrease the crystallinity of a polyester due to its asymmetric structure, it would have been obvious to one of ordinary skilled in the art before the effective filing date of the invention to have incorporated 1 mol% of isophthalic acid (along with 5 mol% adipic acid) in obvious composition of Oda as discussed, when addressing claim 1, to tailor the crystallinity and thus flexibility of the final polyester. Such an obvious composition satisfies the claimed repeat units of 94 mol% RPA1, 1 mol% RPA2 and 5 mol% RPA3. Regarding claims 38 and 45, Oda teaches antioxidant sodium hypophosphite for preventing coloration of the polyamide (para [0033]). Oda further discloses molded articles such as connector parts of automobiles, derived from the polyamide (para [0042]), meeting the claimed requirements. Regarding claims 42 and 43, Oda discloses molded articles such as connector parts of automobiles, derived from the polyamide (para [0042]), meeting the claimed requirements. Regarding claim 51, Oda discloses trans fraction of 50 mol% or more, resulting in cis/trans ratio of 50/50 or more, to lower crystallinity (para [0015), overlapping the claimed requirement. Response to Arguments Applicant's arguments filed on 10/15/2026 have been fully considered, please see the response below. Amended claim 43 overcomes the 112(d) rejection. Applicant argues that Oda does not provide specific guidance on achieving the combination of properties of Tg, Tm and ∆Hf, and adds that it is not straightforward to ensure both high Tg and the required Tm values are achieved by the polyamide. Applicant further argues that Oda does not teach the required cis/trans ratio of the 1,3-BAC moieties. In response, it is highlighted that Oda teaches production example 5 (para [0081]) 1,3-bisaminomethylcyclohexane (1,3-BAC) having a cis/trans ratio of 70/30, and additionally recommends trans mol fractions of 50 mol%, resulting in cis/trans ratio of 50/50 or higher, to lower crystallinity (Oda para [0015]). Thus, applicant’s argument that Oda does not teach the required cis/trans ratio of the 1,3-BAC moieties is not convincing. Oda additionally discusses managing Tg and crystallinity of the polyamide by tailoring the proportions of the dicarboxylic acids (para [0026]), as well as tuning polymer molecular weight (para [0037]). Oda teaches the same monomers and renders the repeat unit proportions obvious, and also provides the molecular weight Mn value (24,550 g/mol, Example 5, Table 2) which is within the recommended range of the instant specification (specification, para [0030]), and thus the obvious polyamide composition of Oda would be reasonably expected to possess the required thermal properties. The burden is shifted to the applicant to provide the reasoning as to why Oda’s obvious composition which satisfies the claimed repeat units of 95 mol% RPA1 and 5 mol% RPA3, with 1,3-bisaminomethylcyclohexane cis/trans ratio of 70/30, while maintaining the molecular weight of Mn 24,550 g/mol, would not achieve the required Tg, Tm and ∆Hf. Applicant’s arguments are found to be unpersuasive, and in the absence of a showing of new or unexpected results, the instant polyamide is not distinguished over the obvious polyamide of Oda. Reference Oda continues to provide the support for maintaining the rejection. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Surbhi M Du whose telephone number is (571)272-9960. The examiner can normally be reached M-F 9:00 am to 5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi (Riviere) Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /S.M.D./ Examiner Art Unit 1765 /JOHN M COONEY/Primary Examiner, Art Unit 1765
Read full office action

Prosecution Timeline

Feb 05, 2024
Application Filed
Jul 15, 2026
Non-Final Rejection mailed — §103
Oct 15, 2026
Response Filed
Nov 13, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12753278
CHLOROSULFONATED POLYPROPYLENE CARBONATE, AND PRODUCTION METHOD AND USE THEREOF
4y 1m to grant Granted Oct 06, 2026
Patent 12753300
Thermoplastic Resin Composition
3y 8m to grant Granted Oct 06, 2026
Patent 12729265
POLYURETHANES FROM DEPOLYMERIZED LIGNIN CONTAINING LIGNIN MONOMERS
3y 11m to grant Granted Sep 08, 2026
Patent 12714094
CRYOPROTECTANT POLYMERS AND METHODS OF MAKING AND USING THEREOF
4y 7m to grant Granted Aug 25, 2026
Patent 12679961
FILLED AUTOMOTIVE POLYPROPYLENE COMPOSITION CONTAINING RECYCLATES
3y 5m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
67%
Grant Probability
96%
With Interview (+29.0%)
3y 2m (~5m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 124 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month